However, ultimately, an improved understanding of the molecular mechanisms underlying IGF1R/CXCR4 transactivation, including the role of PI3K signal transduction pathways, in the progression of breast cancer metastasis and invasion may lead to development of more effective diagnostic and therapeutic strategies. The gene discussed is IGF1R; the disease is breast carcinoma.